Additionally, the systemic infusion of IL-6 NAb attenuates the increase in BBB permeability caused by ischemia [56], while high levels of IL-6 promote BBB disruption and decrease Pgp in Alzheimer’s disease [57]. This evidence concerns the gene IL6 and Alzheimer disease.